Fab’entech raises 8.5 million euros to accelerate the development and marketing of its passive immunotherapy treatments.

Lyon, dated 31 January 2020: Fab’entech, a Lyon-based biopharmaceutical company created in 2009 and specialised in immunotherapy for emergency situations, completes a new round of fundraising of 8.5 million euros led by Definvest, the fund of the Armed forces ministry managed by Bpifrance, with the participation of the Institut Mérieux and of its historical investors, …

Fab’entech raises 8.5 million euros to accelerate the development and marketing of its passive immunotherapy treatments. Read More »